Fisher Asset Management LLC Trims Stake in iShares U.S. Pharmaceuticals ETF $IHE

Fisher Asset Management LLC lessened its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 3.0% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,886,342 shares of the company’s stock after selling 90,349 shares during the quarter. Fisher Asset Management LLC owned about 0.36% of iShares U.S. Pharmaceuticals ETF worth $209,433,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Wealthcare Advisory Partners LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 4.4% in the third quarter. Wealthcare Advisory Partners LLC now owns 5,115 shares of the company’s stock valued at $371,000 after buying an additional 217 shares during the last quarter. Arkansas Financial Group Inc. increased its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.2% in the 3rd quarter. Arkansas Financial Group Inc. now owns 7,415 shares of the company’s stock valued at $561,000 after acquiring an additional 230 shares during the period. Envestnet Asset Management Inc. raised its position in iShares U.S. Pharmaceuticals ETF by 2.8% in the 2nd quarter. Envestnet Asset Management Inc. now owns 8,633 shares of the company’s stock valued at $566,000 after purchasing an additional 238 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its position in iShares U.S. Pharmaceuticals ETF by 6.0% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 4,207 shares of the company’s stock valued at $316,000 after purchasing an additional 240 shares during the last quarter. Finally, Capital Investment Advisors LLC boosted its stake in iShares U.S. Pharmaceuticals ETF by 4.4% during the 3rd quarter. Capital Investment Advisors LLC now owns 7,437 shares of the company’s stock worth $540,000 after purchasing an additional 313 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $91.31 on Tuesday. The company has a market capitalization of $1.02 billion, a P/E ratio of 17.75 and a beta of 0.54. iShares U.S. Pharmaceuticals ETF has a 1 year low of $58.97 and a 1 year high of $92.29. The company’s fifty day moving average is $87.71 and its two-hundred day moving average is $80.27.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.